Clinical trial
A Multi-center, Study Investigating a New, Oral Growth Hormone Secretagogue (GHS)(AEZS 130, Formerly Ardana (ARD)-07) as a Growth Hormone (GH) Stimulation Test in Terms of Safety and Efficacy
NCT00448747 is registered in ClinicalTrials.gov with AEterna Zentaris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Study Investigating a New, Oral Growth Hormone Secretagogue (GHS)(AEZS 130, Formerly Ardana (ARD)-07) as a Growth Hormone (GH) Stimulation Test in Terms of Safety and Efficacy
- Lead sponsor
- AEterna Zentaris
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2007
- Completion date
- July 31, 2011
- Enrollment
- 101 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
diagnosis of adult growth hormone deficiency (agdh)